SMEITINK, Johannes Albertus Maria,BEYRATH, Julien David
申请号：
AU2018371152
公开号：
AU2018371152A1
申请日:
2018.11.22
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The invention relates to amide-derivatives of 6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid for use in a treatment for preventing or suppressing symptoms associated with mood disorders, headaches and migraine. The compounds of the invention can be used to treat any subject suffering from a mood disorder,headaches and/or migraine but can specifically be used to treat a mood disorder,headaches and/or migraine in patients suffering from a mitochondrial disease.
